Michael Stock, Chief Financial Officer of Liberty Energy Inc. (NYSE:LBRT), filed a Form 4 on September 1, 2026, disclosing the sale of 6,666 shares of Class A Common Stock on September 1, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Walter E. Carter, a director of TeraWulf Inc., filed a Form 4 on September 1, 2026, disclosing the sale of 130,626 shares of TeraWulf common stock on August 31, 2026.
Director Michelle Felman filed a Form 4 with the SEC on September 1, 2026, reporting a gift of 16,086 shares of Acacia Research Corp common stock made on August 28, 2026, to an irrevocable trust for the benefit of her son.
Cole G. Carter, Chief Administrative Officer of CoreCivic, Inc. (NYSE:CXW), filed a Form 4 on September 1, 2026, reporting the sale of 12,500 shares of common stock pursuant to a Rule 10b5-1 trading plan.
Eric Carre, Executive Vice President and Chief Financial Officer of Halliburton Co, filed a Form 4 on September 1, 2026, disclosing the sale of 24,777 shares of common stock on August 31, 2026, pursuant to a Rule 10b5-1 trading plan.
Johnson Lau (Shun-Pong), formerly Vice President of Finance of SL Science Holding Ltd, filed a statement of changes in beneficial ownership on September 1, 2026, disclosing his resignation from that role effective August 31, 2026, and his resulting exit from Section 16 reporting obligations.
Stephen Philip Ribaudo, Executive Vice President and Chief Operating Officer of Timken Co (NYSE:TKR), filed a Form 4 on September 1, 2026, disclosing the acquisition of three separate grants of restricted share units totaling 23,150 units.
A Form 4 filed on September 1, 2026, discloses that H. Lynn Moore Jr., President and CEO of Tyler Technologies Inc (NYSE:TYL), exercised stock options and sold common shares on August 28, 2026.
Sprouts Farmers Market, Inc. filed an 8-K with the SEC on September 1, 2026, disclosing that its Board of Directors appointed Nick Konat as Chief Executive Officer effective January 4, 2027, as part of a long-term succession process.
Alamar Biosciences, Inc. filed a current report on Form 8-K on September 1, 2026, disclosing that its board of directors appointed Robert Ragusa as a Class I Director, effective September 1, 2026.